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Supplementary Figure 1. Summary of study design. 
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Supplementary Figure 2. Quantile-quantile plot of 2,684,393 single nucleotide polymorphisms (SNPs) from 
the meta-analysis of up to N=26,836 discovery samples. The black dots represent observed P values and 
the black line represents the expected P values under the null distribution. The red dots represent 
observed P values after excluding the previously identified ADCY5 and CCNL1 signals. 
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Supplementary Figure 3. Manhattan plot of the association P values for birth weight from the discovery 
meta-analysis (n = up to 26,836). The -log10 of the P value for each of 2,684,393 SNPs (y-axis) is plotted 
against the genomic position (NCBI Build 36; x-axis). Association signals that reached genome-wide 
significance (P < 5x10-8) in the global meta-analysis of discovery and follow-up studies are shown in red. 
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Supplementary Figure 4. Forest plots of the associations between birth weight and (a) CCNL1, (b) ADCY5, 
(c) HMGA2, (d) CDKAL1, (e) 5q11.2, (f) LCORL and (g) ADRB1 in Europeans. In each plot, the dashed red line 
indicates the effect size from the overall meta-analysis of discovery and follow-up samples.  
 
(a) CCNL1 (overall n = 61,142; P = 3.6x10-38; heterogeneity P = 0.49) 
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(b) ADCY5 (overall n = 61,509; P = 5.5x10-20; heterogeneity P = 0.69) 
 
  
8 
 
 
 
 
(c) HMGA2 (overall n = 68,655; P = 1.4x10-19; heterogeneity P = 0.82) 
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(d) CDKAL1 (overall n = 68,822; P = 1.5x10-18; heterogeneity P = 0.57) 
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(e) 5q11.2 (overall n = 53,619; P = 4.6x10-8; heterogeneity P = 0.40) 
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(f) LCORL (overall n = 55,877; P = 4.6x10-11; heterogeneity P = 0.16) 
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(g) ADRB1 (overall n = 49,660; P = 3.6x10-9; heterogeneity P = 0.97) 
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Supplementary Figure 5. Plot of type 2 diabetes effect size against birth weight effect size (n=5,327 
ALSPAC mother-child pairs) for loci achieving P < 0.01 in the discovery meta-analysis. Circles are unadjusted 
for maternal genotype; triangles are adjusted for maternal genotype. 
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Supplementary Figure 6. Associations between SNP rs900400 near CCNL1 and weight from birth to 6 
months in seven studies with available postnatal data. The vertical lines show 95% confidence intervals 
around the effect size estimates. Total sample sizes: n = 15,090 (0 months); n = 6,952 (1 month); n = 5,720 
(2 months); n = 7,857 (3 months); n = 7,535 (6 months). 
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Supplementary Figure 7. Forest plots of the associations between birth weight and (a) CCNL1, (b) ADCY5, 
(c) HMGA2, (d) CDKAL1, (e) 5q11.2, (f) LCORL and (g) ADRB1 in non-Europeans. The overall European result 
is shown for comparison. The non-European studies are from East/Southeast Asia (Chinese [SCORM] and 
Filipino [CLHNS]), Africa (African-American [CHOP-AfAm], Mandinka [MRC Keneba] and Moroccan 
[Generation R]), Middle East (Arab [SAUDI], Turkish [Generation R]), and South America (Surinamese 
[Generation R]). 
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(f) LCORL 
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(g) ADRB1 
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Supplementary Figure 8. Ethnicity-specific regional plots for (a) CCNL1 and (b) ADCY5 in European 
(n=26,813), East/Southeast Asian (n=2,135) and African American (n=6,315). Directly genotyped or 
imputed SNPs are plotted as a function of genomic position (NCBI Build 36). In each panel, the European 
discovery stage SNP taken forward for follow-up, i.e. rs900400 in CCNL1 and rs9883204 in ADCY5, is 
represented by a purple diamond. Estimated recombination rates are plotted to reflect the local LD 
structure around these SNPs (according to a blue to red scale from r2 = 0 to 1, based on pairwise r2 values 
from HapMap CEU, JPT+CHB, and YRI, respectively).
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Supplementary Figure 9. Box plot showing the percentage variance in birth weight explained by five related 
characteristics (x-axis) in all 43 European studies. Diamond = median; box = interquartile range; whiskers = 
median +/- 2*interquartile range; circle = outlier. 
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